文献速递慢性肾脏病

BOLD-MRI评估高危2型糖尿病患者与匹配对照者的肾脏氧合

Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

这项匹配横断面研究纳入20例2型糖尿病合并正常至中度慢性肾脏病(1-3A期)患者与20例匹配非糖尿病对照,采用BOLD-MRI及12层同心圆法分析肾脏氧合。两组肾氧合从皮质到髓质均显著降低(P<.01),但组间无显著差异[0.71/s(95%CI -0.28-1.7),P=.16]。BOLD-MRI个体内变异系数中位数为1.2%至7.0%。

要点

  • 2型糖尿病合并正常至中度CKD患者BOLD-MRI肾氧合与匹配对照无显著差异。
  • 两组肾氧合从皮质到髓质均显著降低(P<.01)。
  • BOLD-MRI个体内变异系数中位数为1.2%至7.0%,重复性较好。

核心结论

  • 2型糖尿病合并正常至中度CKD患者经BOLD-MRI及12层同心圆法测量的肾氧合似乎并不低于匹配对照。
  • BOLD-MRI个体内变异系数低,似乎是研究2型糖尿病患者肾氧合的可靠方法。

研究设计与样本

  • 匹配横断面研究,纳入20例2型糖尿病患者(年龄69.2±4.7岁,糖尿病病程10.5±6.7年,男性55.6%)和20例匹配非糖尿病对照(平均年龄68.8±5.4岁,男性55.%)。
  • 所有受试者接受BOLD-MRI并以12层同心圆法分析;为评估重复性,糖尿病组7例和对照组9例接受两次扫描。

主要发现

  • 两组肾氧合从皮质到髓质均显著降低(P<.01)。
  • 组间肾氧合无显著差异[0.71/s(95%CI -0.28-1.7),P=.16]。
  • 个体内变异系数中位数为1.2%至7.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic kidney disease (DKD) accounts for ∼50% of end-stage kidney disease. Renal hypoxia is suggested as a main driver in the pathophysiology underlying chronic DKD. Blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) has made noninvasive investigations of renal oxygenation in humans possible. Whether diabetes per se contributes to measurable changes in renal oxygenation by BOLD-MRI remains to be elucidated. We investigated whether renal oxygenation measured with BOLD-MRI differs between people with type 2 diabetes (T2DM) with normal to moderate chronic kidney disease (CKD) (Stages 1-3A) and matched controls. The repeatability of the BOLD-MRI method was also assessed. METHODS: In this matched cross-sectional study, 20 people with T2DM (age 69.2 ± 4.7 years, duration of diabetes 10.5 ± 6.7 years, male 55.6%) and 20 matched nondiabetic controls (mean age 68.8 ± 5.4 years, male 55.%) underwent BOLD-MRI analysed with the 12-layer concentric object method (TLCO). To investigate the repeatability, seven in the T2DM group and nine in the control group were scanned twice. RESULTS: A significant reduction in renal oxygenation from the cortex to medulla was found in both groups (P < .01) but no intergroup difference was detected [0.71/s (95% confidence interval -0.28-1.7), P = .16]. The median intraindividual coefficient of variation (CV) varied from 1.2% to 7.0%. CONCLUSION: T2DM patients with normal to moderate CKD do not seem to have lower renal oxygenation when measured with BOLD-MRI and TLCO. BOLD-MRI has a low intraindividual CV and seems like a reliable method for investigation of renal oxygenation in T2DM.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sørensen SS, Gullaksen S, Vernstrøm L, et al. Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls. Nephrol Dial Transplant. 2023. PMID: 35612982. doi:10.1093/ndt/gfac186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。